InsidersTradesSigma
Xbrane Biopharma AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the Xbrane Biopharma AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Xbrane Biopharma AB has logged 4 public disclosures. Market capitalisation: €218.4m. The latest transaction was reported on 21 January 2021 (Purchase). Among the most active insiders: Anette Lindqvist. All data is free.
4
Insider Decl.
0
Thresholds
€42,715
4 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Fundamental score
Ranked 10,681 of 25,927 companies
56.5
score / 100
Value50
Quality63
FCF yld-179%
Earn yld58%
EV/EBITDA·
ROE-20%
Gross mgn59%
Net mgn83%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 21 January 2021
Declarations4 total
1,500 shares@ SEK 82.54100.0% of flowAktieFI:A001P657-1
Ideal exit: 17 Oct 2021 (T+270)
750 shares@ SEK 76.20100.0% of flowAktieFI:A001P598-1
Ideal exit: 15 Oct 2021 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
2,000 shares@ SEK 78.40100.0% of flowAktieFI:A001P565-1
Ideal exit: 12 Oct 2021 (T+270)
1,150 shares@ SEK 81.60100.0% of flowAktieFI:A001P393-1
Ideal exit: 5 Oct 2021 (T+270)
4 of 4 declarations